How many patients must we treat for Helicobacter pylori infection to prevent a recurrent duodenal ulcer hemorrhage?

Gastrointestinal Endoscopy

Volumn 43, Issue 2 PART 1, 1996, Pages 175-

  Howden, Colin W ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DUODENUM BLEEDING; HELICOBACTER PYLORI; HUMAN; LETTER; PRIORITY JOURNAL; RANDOMIZATION; RECURRENT DISEASE; RISK ASSESSMENT; RISK MANAGEMENT;

EID: 58149206644     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5107(06)80131-8     Document Type: Letter

References (4)

1. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease
2. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage
3. An assessment of clinically useful measures of the consequences of treatment
4. The number needed to treat: a clinically useful measure of treatment effect